[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.204.108.121. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
February 1963

Problems of Continuous Chemotherapy by Arterial Catheters

Author Affiliations

NEW YORK; NAIROBI, KENYA
From the Division of Clinical Chemotherapy, Sloan-Kettering Institute for Cancer Research, New York, and the Departments of Head and Neck Surgery and of Gynaecology, King George VI Hospital, Nairobi, Kenya.

Arch Surg. 1963;86(2):323-330. doi:10.1001/archsurg.1963.01310080147033
Abstract

Introduction  Intra-arterial administration of chemotherapeutic agents is used by an increasing number of investigators as a means of obtaining a higher drug concentration in the tumor than in the remainder of the body. In contrast to the alkylating agents, antimetabolites have to be given over a period of at least several days in order to be effective.Sullivan first demonstrated, in 1958, that such treatment with methotrexate can be successful but that for optimal results 2 to 3 adequate courses of treatment are the minimum requirement. This implies that the intra-arterial catheter has to function properly for at least 6 weeks if not longer.In a report on 76 patients undergoing treatment through intra-arterial catheters, Duff et al. already noted complications such as bleeding, infection, or leakage, jeopardizing in a few cases even 1 adequate course of treatment. The nature of these complications suggested that they might arise more frequently

First Page Preview View Large
First page PDF preview
First page PDF preview
×